Results 191 to 200 of about 1,274 (258)

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial. [PDF]

open access: yesNat Med
Rampal RK   +27 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy